Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Preferred Stock Liabilities (2023 - 2024)

Historic Preferred Stock Liabilities for Upstream Bio (UPB) over the last 2 years, with Q3 2024 value amounting to $380.9 million.

  • Upstream Bio's Preferred Stock Liabilities rose 6492.69% to $380.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $380.9 million, marking a year-over-year increase of 6492.69%. This contributed to the annual value of $230.9 million for FY2023, which is N/A changed from last year.
  • Per Upstream Bio's latest filing, its Preferred Stock Liabilities stood at $380.9 million for Q3 2024, which was up 6492.69% from $230.9 million recorded in Q4 2023.
  • In the past 5 years, Upstream Bio's Preferred Stock Liabilities registered a high of $380.9 million during Q3 2024, and its lowest value of $230.9 million during Q3 2023.